Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiac surgery haemostatic resuscitation trial
ACTRN12615000315516Phase 4Not yet recruiting
- Sponsor
- St. Vincent's Health Australia
- Start
- May 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of Fibrinogen human and prothrombin complex in perioperative bleeding and coagulopathy (2 arms), sponsored by St. Vincent's Health Australia. Primary endpoint: Red blood cell transfusion rate and total transfusion amount. Planned start May 2016; status: not yet recruiting.
02
Drugs
Fibrinogen humanprothrombin complex
03
Conditions
perioperative bleedingcoagulopathy
Beyond the preview
Go deeper on ACTRN12615000315516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000315516.